Where Apple will likely invest in healthcare

All signs point to technology giant Apple continuing its dive into the healthcare space with new services or devices. With its recent foray into health monitoring through its Apple Watch, the company is poised to make a splash in other areas, Fast Company predicted.

Beyond monitoring heart rate, Apple could potentially have a future in blood pressure monitoring and management, diabetes management and sleep science, the publication stated. Those three areas cover chronic conditions and related symptoms that can contribute to higher healthcare costs and more healthcare services usage. Better management and monitoring of these conditions at home could potentially lead to better interventions that reduce hospitalizations and lower overall costs.

Healthcare organizations have already linked up with Apple to monitor hip and knee replacement surgery patients via Apple Watches. Apple has also signaled it may enter the field of medical imaging with a relatively new patent.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.